Previous 10 | Next 10 |
Internationally renowned ophthalmologist, Gerd Auffarth, MD, ranked as one of the “100 most influential personalities in ophthalmology worldwide" in the 2020 Power List published by The Ophthalmologist magazine Julian Gangolli, former President of the North American...
Shares of Krystal Biotech (KRYS) have risen by over 200% since my July 2018 article recommended readers accumulate shares based on optimism for the gene therapy pioneer's STAR-D platform and its potential to address multiple rare skin diseases. On the other hand, performance is only slightly...
RenovaCare ( OTCPK:RCAR +0.8% ) announces that its SkinGun , a patented device for spraying self-donated stem cells for the regeneration of skin and other organs/tissues, is being used in a preclinical study at King's College London to apply gene-supplemented cells (gene therapy) for ac...
Allakos (NASDAQ: ALLK ) initiated with Underperform rating and $34 (42% downside risk) price target at SMBC Nikko. More news on: Allakos Inc., Avadel Pharmaceuticals plc, Krystal Biotech, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Krystal Biotech (NASDAQ: KRYS ): FY GAAP EPS of -$1.20 beats by $0.01 . Cash, cash equivalents and short-term investments of $193.7M Shares +1.8% Press Release More news on: Krystal Biotech, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news,
Phase 3 trial of B-VEC (Beremagene Geperpavec, previously “KB103”) to treat dystrophic epidermolysis bullosa (“DEB”) to start in 1H 2020 Interim results on Phase 1/2 clinical study on KB105 to be announced in 1H 2020 Planned filing of two Investigational...
PITTSBURGH, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. , (“Krystal”) (NASDAQ: KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from skin diseases, today announced the appointment of Kathryn Romano...
PITTSBURGH, Feb. 21, 2020 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from skin diseases, today announced that Krish S. Krishnan, chairman a...
Krystal Biotech (NASDAQ: KRYS ) announces the ground breaking of the second commercial gene therapy facility in Findlay Township, Pennsylvania. More news on: Krystal Biotech, Inc., Healthcare stocks news, Read more ...
PITTSBURGH, Jan. 24, 2020 (GLOBE NEWSWIRE) -- Krystal Biotech , Inc. (Nasdaq:KRYS), a gene therapy company developing medicines to treat rare diseases, announced today the ground breaking of the second commercial gene therapy facility in Findlay Township, Pennsylvania. The Findlay-based ...
News, Short Squeeze, Breakout and More Instantly...
PITTSBURGH, July 26, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that it will report its second quarter 2024 financial results on Monday, August 5, 2024, prior to the open of U....
A look at the top 10 most actives in the United States Serve Robotics Inc. (SERV) rose 187.1% to $7.55 on volume of 255,453,115 shares 60 Degrees Pharmaceuticals Inc. (SXTP) rose 10.2% to $0.271 on volume of 224,640,171 shares NVIDIA Corporation (NVDA) fell 2.6% to $117.93 on volume of 21...
A look at the top 10 most actives in the United States 60 Degrees Pharmaceuticals Inc. (SXTP) rose 98.3% to $0.4878 on volume of 116,444,604 shares NVIDIA Corporation (NVDA) fell 0.2% to $120.8 on volume of 26,900,560 shares Serve Robotics Inc. (SERV) rose 61.2% to $4.2399 on volume of 25...